Authors:
Drusano, GL
Preston, SL
Hardalo, C
Hare, R
Banfield, C
Andes, D
Vesga, O
Craig, WA
Citation: Gl. Drusano et al., Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint, ANTIM AG CH, 45(1), 2001, pp. 13-22